The Instituto de Medicina Tropical Alexander von Humboldt is a tropical medicine institute at Cayetano Heredia University in Lima, Peru. It was founded in 1968, under the direction of Prof. Hugo Lumbreras Cruz, a distinguished Peruvian doctor and parasitologist.

During the past decade, Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bioneer Corporation" with 1 trials as a collaborator, "Kenya Medical Research Institute" with 1 trials as a collaborator and "Universidad Peruana Cayetano Heredia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia" are "Cutaneous Leishmaniasis" (2 trials), "Behavior, Health" (1 trials), "HIV Infections" (1 trials), "HTLV-I Infections" (1 trials) and "Pediatric ALL" (1 trials). Many other conditions were trialed in "Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia" in a lesser frequency.

Most popular intervention types in "Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia" are "Drug" (4 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by ""Raltegravir" and "Zidovudine"" (1 trials), "2N(t)RTI" (1 trials), "Imiquimod" (1 trials), "Increasing the completion of IPT" (1 trials) and "Miltefosine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".